» Articles » PMID: 25537440

The Perception of Health-related Quality of Life in Colon Cancer Patients During Chemotherapy: Differences Between Men and Women

Overview
Publisher Springer
Date 2014 Dec 25
PMID 25537440
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

There is a need for more information on the quality of life (QoL) in patients undergoing chemotherapy. We wanted to investigate the perception of health status in colon cancer patients before, 3 and 6 months after chemotherapy. A secondary purpose was to assess the different perceptions of QoL between men and women during and after adjuvant or palliative therapy. We investigated 100 patients throughout chemotherapy for colon cancer. Data were collected through the SF-36 questionnaire. The score of all variables analyzed in the study group was lower than in the control group, which indicates a lower performance status, more marked in the female sex. Patients were then subdivided by the state of disease (localized or metastatic) and the variables, were evaluated before, 3 and 6 months after therapy. In patients treated with adjuvant treatment, there was a worsening of the performance status, followed by an increase after 6 months. We found that after 3 months of therapy, affected male patients perceived more limitations in carrying out their work, other daily activities and social relationships, owing to both their emotional state and their physical health. In metastatic patients the values of the eight variables decreased dramatically after 6 months, indicating a worsening of the QoL. In patients who received adjuvant treatment there was a certain worsening of the health status at 3 months, followed by a general improvement after 6 months. This improvement was not observed in patients undergoing palliative therapy. Several differences were observed between men and women in performance status after treatment.

Citing Articles

Predictive factors associated with health-related quality of life in patients with colorectal cancer in Iran: a cross-sectional study.

Dahouri A, Sahebihagh M, Gilani N BMJ Open. 2024; 14(9):e086544.

PMID: 39343452 PMC: 11440214. DOI: 10.1136/bmjopen-2024-086544.


The Impact of Bevacizumab and Chemotherapy on Quality of Life in Metastatic Colorectal Cancer Patients.

Moisuc D, Marinca M, Matei A, Popovici L, Cianga P Healthcare (Basel). 2023; 11(4).

PMID: 36833125 PMC: 9956224. DOI: 10.3390/healthcare11040591.


Health-Related Quality of Life Following Simultaneous Resection for Synchronous Colorectal Cancer Liver Metastases.

Griffiths C, Karanicolas P, Gallinger S, Wei A, Francescutti V, Serrano P Ann Surg Oncol. 2022; 30(3):1331-1338.

PMID: 36350458 PMC: 11005481. DOI: 10.1245/s10434-022-12696-6.


Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer.

Manjelievskaia J, Brown D, McGlynn K, Anderson W, Shriver C, Zhu K JAMA Surg. 2017; 152(5):452-459.

PMID: 28122072 PMC: 5806125. DOI: 10.1001/jamasurg.2016.5050.

References
1.
Peddle C, Au H, Courneya K . Associations between exercise, quality of life, and fatigue in colorectal cancer survivors. Dis Colon Rectum. 2008; 51(8):1242-8. DOI: 10.1007/s10350-008-9324-2. View

2.
Theodoropoulos G, Karantanos T, Stamopoulos P, Zografos G . Prospective evaluation of health-related quality of life after laparoscopic colectomy for cancer. Tech Coloproctol. 2012; 17(1):27-38. DOI: 10.1007/s10151-012-0869-7. View

3.
Yau T, Chan P, Ching Chan Y, Wong B, Liang R, Epstein R . Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies. Aliment Pharmacol Ther. 2008; 27(11):997-1005. DOI: 10.1111/j.1365-2036.2008.03684.x. View

4.
Chung K, Saltz L . Adjuvant therapy of colon cancer: current status and future directions. Cancer J. 2007; 13(3):192-7. DOI: 10.1097/PPO.0b013e318074d26e. View

5.
Steginga S, Lynch B, Hawkes A, Dunn J, Aitken J . Antecedents of domain-specific quality of life after colorectal cancer. Psychooncology. 2008; 18(2):216-20. DOI: 10.1002/pon.1388. View